The growing multi-state research organization brings expanded therapeutic expertise and patient access to hyperCORE's collaborative global network
TAMPA, FL, March 10, 2026 /24-7PressRelease/ -- hyperCORE International is pleased to welcome Empathx Clinical Research, based in Tampa Bay, Florida, to its global partner site network as the clinical research organization continues to expand its patient reach and capabilities across the United States.
Empathx Clinical Research operates eight clinical trial sites across six states: California, Florida, Massachusetts, Michigan, Missouri, and Texas. The organization focuses on advancing clinical trials in key therapeutic areas including cardio-metabolic disease, central nervous system (CNS) disorders, nephrology, and infectious disease.
EmpathX's site portfolio includes both dedicated, stand-alone research centers and integrated research sites embedded within large, specialized physician practices. This hybrid model brings clinical research directly into the care environments where patients already receive treatment, expanding access to trials while supporting efficient study execution.
EmpathX Clinical Research is led by CEO Dustin Owen, who noted that the organization's decision to join hyperCORE reflects a shared commitment to collaboration and quality among leading research site networks. Prior to joining EmpathX, Owen served as Senior Vice President of Accelerated Enrollment Solutions at Thermo Fisher Scientific/PPD, where he led global clinical research site operations.
"Joining hyperCORE is about partnering with like-minded, high quality site networks with similar mission," Owen shared. "The partnership enhances our ability to work with sponsors to bring life- changing therapies to our communities. Our added scale, geographic coverage, and access to diverse patient populations gives sponsors a reliable solution for delivering on clinical trials."
"Empathx Clinical Research brings a strong blend of therapeutic expertise, geographic reach, and innovative site integration to our partner network," said Nicholas Focil, President of hyperCORE International. "Their approach to embedding research in clinical care aligns with hyperCORE's mission to expand patient access and deliver high-quality trials, and we are pleased to welcome Empathx to the network."
hyperCORE International is a partner site network of leading clinical research organizations, with more than 80 active trial sites across five countries. Collectively, hyperCORE partners have completed over 7,000 studies involving more than 140,000 randomized participants. The network aligns independent organizations around harmonized operational frameworks that support high-quality, consistent trial execution.
hyperCORE is committed to advancing clinical research through safe, ethical studies, strong enrollment, and superior patient retention.
---
Press release service and press release distribution provided by https://www.24-7pressrelease.com
